首页|癫痫清颗粒通过调控NLRP3/Caspase-1通路对阿尔茨海默病小鼠Tau蛋白的影响

癫痫清颗粒通过调控NLRP3/Caspase-1通路对阿尔茨海默病小鼠Tau蛋白的影响

扫码查看
目的 研究癫痫清颗粒对阿尔茨海默病小鼠Tau蛋白的影响.方法 将P301S突变Tau转基因小鼠随机分为模型组、MCC950组(NLRP3抑制剂,10 mg/kg)、癫痫清颗粒组(12.48 g/kg)、MCC950+癫痫清颗粒组,另以C57BL/6小鼠为对照组.给药5个月后,通过Y迷宫实验、Morris水迷宫实验检测小鼠学习记忆能力;HE染色观察脑组织形态学改变;免疫组化法检测脑组织Caspase-1、GSDMD蛋白表达;免疫荧光法检测脑组织Tau蛋白表达;Western blot法检测脑组织Tau、p-Tau(ser202)、p-Tau(thr205)、NLRP3、Caspase-1、IL-1β、IL-18蛋白表达.结果 与对照组比较,模型组小鼠自发交替反应率和穿越平台次数降低(P<0.05,P<0.01);脑组织海马区形态异常,神经元数目减少;脑组织Caspase-1、GSDMD阳性表达增加(P<0.05),可见大量的棕黄色颗粒沉积在细胞质中;脑组织海马和皮质部位Tau、p-Tau(ser202)、p-Tau(thr205)及NLRP3、Caspase-1、IL-1β、IL-18蛋白表达均升高(P<0.05,P<0.01).与模型组比较,癫痫清颗粒组小鼠自发交替反应率和穿越平台次数均升高(P<0.05);脑组织结构完整,神经元细胞排列整齐有序;脑组织Caspase-1、GSDMD阳性表达减少(P<0.05);脑组织Tau、p-Tau(ser202)、p-Tau(thr205)及NLRP3、Caspase-1、GSDMD、IL-1β、IL-18蛋白表达降低(P<0.05,P<0.01).结论 癫痫清颗粒可能通过调控NLRP3/Caspase-1通路抑制阿尔茨海默病小鼠Tau蛋白表达.
Effects of Dianxianqing Granules on Tau protein in a mouse model of Alzheimer' s disease via NLRP3/Caspase-1 pathway
AIM To study the effects of Dianxianqing Granules on Tau protein in a mouse model of Alzheimer's disease (AD).METHODS The mice expressing P301S mutant Tau variant were randomly divided into the model group,the MCC950 group (NLRP3 inhibitor,10 mg/kg),the Dianxianqing Granules group (12.48 g/kg),the MCC950+Dianxianqing Granules group,in contrast to the C57BL/6 mice of the control group.After 5 months of administration,the mice had their learning and memory ability tested by Y maze test and Morris water maze test;their cerebral morphological changes observed by HE staining;their cerebral expressions of Caspase-1 and GSDMD proteins detected by immunohistochemical method;their expression of cerebral Tau protein detected by immunofluorescence;and their cerebral expressions of Tau,p-Tau (ser202),p-Tau (thr205),NLRP3,Caspase-1,IL-1β and IL-18 detected by Western blot.RESULTS Compared with the control group,the model group displayed decreased rate of spontaneous alternate reaction and times of crossing platform (P<0.05,P<0.01);abnormal hippocampal morphology,decreased number of neurons,increased cerebral positive expressions of Caspase-1 and GSDMD (P<0.05);deposition of a large number of brown granules in cytoplasm,and increased protein expressions of Tau,p-Tau (ser202),p-Tau (thr205),NLRP3,Caspase-1,IL-1βand IL-18 in the hippocampus and the cortex (P<0.05,P<0.01).Compared with the model group,the group intervened with Dianxianqing Granules demonstrated both increased rate of spontaneous alternate reaction and times of crossing platform (P<0.05);complete and normal morphology of the brain,a diversity of fine neurons,reduced cerebral positive expressions of Caspase-1 and GSDMD (P<0.05);and decreased protein expressions of Tau,p-Tau (ser202),p-Tau (thr205),NLRP3,Caspase-1,IL-1β and IL-18 in the hippocampus and the cortex (P<0.05,P<0.01).CONCLUSION Dianxianqing Granules may inhibit Tau protein expression in the mouse model of AD via NLRP3/Caspase-1 pathway.

Dianxianqing GranulesAlzheimer's diseaseTau proteinNLRP3/Caspase-1 pathway

夏春鹏、齐越、董笑博、房小楠、李纪彤、黄培池、贾冬、明彩荣

展开 >

辽宁中医药大学,辽宁 沈阳 110847

宁波大学附属第一医院全科医学科,浙江 宁波 315010

江苏省徐州医药高等职业学校药学技术系,江苏 徐州221116

癫痫清颗粒 阿尔茨海默病 Tau蛋白 NLRP3/Caspase-1通路

2024

中成药
国家食品药品监督管理局,信息中心中成药信息站,上海中药行业协会

中成药

CSTPCD北大核心
影响因子:1.217
ISSN:1001-1528
年,卷(期):2024.46(12)